FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:2359-2361 June 5, 2003 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Møller, J. E. PubMed Citation

To the Editor: Møller et al. (March 13 issue)¹ addressed the topic of the progression of carcinoid heart disease. Serial echocardiographic studies were available for 71 of the 273 referred patients. The median level of urinary 5-hydroxyindoleacetic acid (5-HIAA) excretion at base line in patients with carcinoid heart disease was 209 mg per 24 hours, and in those without carcinoid heart disease it was 110 mg per 24 hours; the median duration of the syndrome was relatively short, at 1.0 and 1.8 years, respectively. Remarkably, data on 5-HIAA levels during the course of this disease are scarce. We therefore studied . . . [Full Text of this Article]

This article has been cited by other articles:

• Kaltsas, G. A., Besser, G. M., Grossman, A. B. (2004). The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors. Endocr. Rev. 25: 458-511 [Abstract] [Full Text]